Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Elevance Health Inc. ANTM NYSE

NYSE • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
72/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$529.05
+9.6%

Elevance Health Inc. (ANTM) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $482.58. It has a SharesGrow Score of 72/100, indicating a above average investment profile with 5 out of 7 criteria passed.

Analyst consensus target is ANTM = $529 (+9.6% upside).

Financials: revenue is $199.1B, +8.4%/yr average growth. Net income is $5.7B, growing at -1.3%/yr. Net profit margin is 2.8% (thin). Gross margin is 89.4% (+63.9 pp trend).

Balance sheet: total debt is $1.2B against $43.9B equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 1.54 (strong liquidity). Debt-to-assets is 1%. Total assets: $121.5B.

Analyst outlook: 27 / 37 analysts rate ANTM as buy (73%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 67/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 94/100 (Pass), Future 73/100 (Pass), Income 30/100 (Fail).

$529.05
▲ 9.63% Upside
Average Price Target
Based on 37 Wall Street analysts offering 12-month price targets for Elevance Health Inc., the average price target is $529.05, with a high forecast of $625.00, and a low forecast of $335.00.
Highest Price Target
$625.00
Average Price Target
$529.05
Lowest Price Target
$335.00

ANTM SharesGrow Score Overview

72/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 67/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 94/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ANTM

✓
VALUE Pass
67/100
ANTM trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $529, implying +9.6% from the current price $483. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
40/100
ANTM: +8.4%/yr revenue is, -1.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
ANTM: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet ANTM: Debt-to-Equity (D/E) ratio 0.03 (conservative), Current ratio is 1.54 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
MOAT Pass
94/100
ANTM: Gross margin is 89.4% (+63.9 pp trend), $115B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 94/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
73/100
Analyst outlook: 27 / 37 analysts rate ANTM as buy (73%). Analyst consensus target is $529 (+9.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
30/100
ANTM: Net profit margin is 2.8%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range466.74-485.745
Volume1.27M
Avg Volume (30D)1.18M
Market Cap$114.59B
Beta (1Y)0.97
Dividend Yield$29.0030
Share Statistics
EPS (TTM)25.28
Shares Outstanding$240.7M
IPO Date2001-10-30
Employees98,200
CEOGail Boudreaux
Financial Highlights & Ratios
Revenue (TTM)$199.13B
Gross Profit$177.95B
EBITDA$9.66B
Net Income$5.66B
Operating Income$156.96B
Total Cash$9.49B
Total Debt$1.25B
Net Debt$-8.24B
Total Assets$121.49B
Price / Earnings (P/E)19.1
Price / Sales (P/S)0.58
Analyst Forecast
1Y Price Target$544.00
Target High$625.00
Target Low$335.00
Upside+12.7%
Rating ConsensusBuy
Analysts Covering37
Buy 73% Hold 27% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS0367521038

Price Chart

Track all markets on TradingView
ANTM
Elevance Health Inc. ↗  ·  NYSE
Healthcare • Medical - Healthcare Plans
466.74 52WK RANGE 485.75

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message